A carregar...

Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults

BACKGROUND: We evaluated an inactivated SARS-CoV-2 vaccine for immunogenicity and safety in adults aged 18-59 years. METHODS: In this randomized, double-blinded and controlled trial, healthy adults received a medium (MD) or a high dose (HD) of the vaccine at an interval of either 14 days or 28 days....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Che, Yanchun, Liu, Xiaoqiang, Pu, Yi, Zhou, Meijian, Zhao, Zhimei, Jiang, Ruiju, Yin, Zhifang, Xu, Mingjue, Yin, Qiongzhou, Wang, Jianfeng, Pu, Jing, Zhao, Heng, Zhang, Ying, Wang, Lichun, Jiang, Ya, Lei, Jin, Zheng, Yan, Liao, Yun, Long, Runxiang, Yu, Li, Cui, Pingfang, Yang, Huijuan, Zhang, Yuehui, Li, Jingyu, Chen, Weiwu, He, Zhanlong, Ma, Kaili, Hong, Chao, Li, Dandan, Jiang, Guorun, Liu, Donglan, Xu, Xingli, Fan, Shengtao, Cheng, Chen, Zhao, Hongling, Yang, Jianbo, Li, Yan, Zou, Yanxiang, Zhu, Youshuai, Zhou, Yaling, Guo, Yingqiu, Yang, Ting, Chen, Hongbo, Xie, Zhongping, Li, Changgui, Li, Qihan
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7717222/
https://ncbi.nlm.nih.gov/pubmed/33165503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa1703
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!